title: Protagonist Therapeutics stock surges after J&J acquisition talks report
source: Yahoo
date: 2025-10-10
url: https://finnhub.io/api/news?id=69e9064bbfd12c1b85b1b29a6a5354623f30685728dae2ba3b7191d57bc2c342
Investing.com -- Protagonist Therapeutics (NASDAQ:PTGX) stock spiked 10% before being halted for volatility after The Wall Street Journal reported that Johnson & Johnson (NYSE:JNJ) is in talks to acquire the biotech company.
